PMID: 9531361Apr 8, 1998Paper

Urinary incontinence in patients who have a TURP/TUIP following prostate brachytherapy

International Journal of Radiation Oncology, Biology, Physics
K Hu, K E Wallner

Abstract

To determine urinary morbidity in patients who have transurethral resection of the prostate (TURP) after 125I brachytherapy. A total of 109 patients with Stage T1-T2 prostatic carcinoma were treated with 125I implantation from 1991 through 1995. Ten patients underwent TURP/transurethral incision of the prostate (TUIP) after brachytherapy to relieve urinary obstruction refractory to nonsurgical management. Patients who developed refractory urinary retention had a slightly larger preimplant prostate volume than those who did not (62 vs. 54 ml; p = 0.16). Seven of the 10 patients developed some degree of permanent urinary incontinence following TURP/TUIP. Urinary incontinence was mild in three patients [Late Effects Normal Tissue Radiation Oncology Group (LENT) score = 1] and severe in four additional patients (LENT score = 3). There was no obvious relationship between the degree of incontinence and use of TURP vs. TUIP, amount of tissue resected, or time between brachytherapy and TURP/TUIP. In five patients for whom detailed urethral radiation dose information was available, the doses were higher than generally recommended. Permanent urinary incontinence is common in patients who require a TURP or TUIP after prostate brachytherap...Continue Reading

References

Jan 1, 1991·Urologia Internationalis·F S Haddad, A Chinichian
Aug 1, 1990·The Journal of Urology·N GreenH Wallack
Apr 1, 1985·British Journal of Urology·L E EdwardsJ Stanek
Oct 1, 1986·International Journal of Radiation Oncology, Biology, Physics·T F DeLaneyG R Prout
May 15, 1995·International Journal of Radiation Oncology, Biology, Physics·K WallnerL Harrison
Jul 1, 1994·International Journal of Radiation Oncology, Biology, Physics·K WallnerL Harrison
Feb 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K WallnerL Harrison
Feb 1, 1997·International Journal of Radiation Oncology, Biology, Physics·K WallnerM Dattoli

❮ Previous
Next ❯

Citations

Aug 27, 2002·Current Treatment Options in Oncology·Anthony L Zietman
May 21, 2003·Current Urology Reports·Rodney J Ellis, Edward Kim
Jul 29, 2003·Current Urology Reports·Robert F Donnell
Dec 6, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·L E BlankK Koedooder
Dec 21, 2000·International Journal of Radiation Oncology, Biology, Physics·N LeeR D Ennis
Apr 5, 2001·International Journal of Radiation Oncology, Biology, Physics·I A BrezovichJ Fiveash
Dec 1, 2001·International Journal of Radiation Oncology, Biology, Physics·T SherertzK Russell
Feb 19, 2002·International Journal of Radiation Oncology, Biology, Physics·Jacob LockeJohn Blasko
Sep 6, 2003·International Journal of Radiation Oncology, Biology, Physics·Hoon K LeeDeborah A Kuban
Dec 31, 2003·International Journal of Radiation Oncology, Biology, Physics·Gregory S MerrickRobert W Galbreath
Sep 7, 1999·International Journal of Radiation Oncology, Biology, Physics·D Y GelblumS Leibel
Oct 4, 2003·Clinical Oncology : a Journal of the Royal College of Radiologists·L Potters
Apr 6, 2004·Brachytherapy·Daniel LandisJohn Blasko
Apr 6, 2004·Brachytherapy·Johnathan NguyenSteven Sutlief
Jan 24, 2012·Brachytherapy·Brian J DavisUNKNOWN American Brachytherapy Society
Jul 28, 2004·International Journal of Radiation Oncology, Biology, Physics·Tracy L McElveenAdam P Dicker
Jun 9, 2004·Prostate Cancer and Prostatic Diseases·S E M Langley, R W Laing
Mar 1, 2012·Neurourology and Urodynamics·Catherine W McGrotherBradley N Manktelow

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.